Last SFr.91.95 CHF
Change Today +0.45 / 0.49%
Volume 5.0M
NOVN On Other Exchanges
Symbol
Exchange
SIX Swiss Ex
Xetra
New York
OTC US
Mexico
SIX Swiss Ex
Frankfurt
As of 11:43 AM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Naomi Kelman

Former Head of OTC Division, Novartis AG
AgeTotal Calculated CompensationThis person is connected to 45 board members in 1 different organizations across 2 different industries.

See Board Relationships
54--
As of Fiscal Year 2012

Background*

Ms. Naomi Kelman has been President of LifeScan North America since July 2009. Ms. Kelman served as the Head of OTC Division at Novartis AG from March 2, 2011 to March 2012. Ms. Kelman oversees the OneTouch business, a U.S. category leader of blood glucose monitoring systems for people with diabetes. Ms. Kelman joined Novartis from Johnson & Johnson where she has held several leadership roles within both the Consumer and Medical Device and Diagnostic Sectors. She served ...

Read Full Background

Corporate Headquarters*

Lichtstrasse 35
Basel, Basel-Stadt 4056

Switzerland

Phone: 41 61 324 11 11
Fax: --

Board Members Memberships*

2010-Present
Director

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOVN:VX SFr.91.95 CHF +0.45

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Alan George Lafley Chairman, Chief Executive Officer, President and Member of Proxy Committee
The Procter & Gamble Company
$6.4M
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Kenneth C. Frazier Chairman and Chief Executive Officer
Merck & Co. Inc.
$1.5M
Serge Weinberg Chairman, Interim Chief Executive Officer, Chairman of Appointments & Governance Committee and Chairman of Strategy Committee
Sanofi
€700.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVARTIS AG-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.